PAAMCP
TGTX icon

Pacific Alternative Asset Management Company (PAAMCO)’s TG Therapeutics TGTX Stock Holding History

Pacific Alternative Asset Management Company (PAAMCO)’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-89,223
Closed -$1.16M – 174
2014
Q3 		$952K Buy
89,223
+76,373
+594% +$708K 0.11% 146
2014
Q2 		$121K Buy
+12,850
New +$82.2K 0.01% 193

Other funds holding TGTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Pacific Alternative Asset Management Company (PAAMCO)'s TGTX Position: Q4 2014 in Review

Pacific Alternative Asset Management Company (PAAMCO) sold out of TG Therapeutics (TGTX) in Q4 2014, closing a stake of 89,223 shares — an estimated $1.16M sold.

Pacific Alternative Asset Management Company (PAAMCO) first reported a position in TGTX in Q2 2014 and held it in 2 quarters. The position peaked at $952K in Q3 2014. 75 funds tracked by Wall St. Rank hold TGTX as of Q4 2014.

  • Pacific Alternative Asset Management Company (PAAMCO) reported no remaining TG Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Pacific Alternative Asset Management Company (PAAMCO) sold 89,223 TG Therapeutics shares in Q4 2014, an estimated $1.16M.
  • Pacific Alternative Asset Management Company (PAAMCO) first reported a position in TG Therapeutics in Q2 2014 and held it in 2 quarters.
  • Pacific Alternative Asset Management Company (PAAMCO)'s TG Therapeutics position peaked at $952K in Q3 2014.
  • 75 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2014.

Based on Pacific Alternative Asset Management Company (PAAMCO)'s 13F filing for Q4 2014, filed 13 Feb 2015.